Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Community and Private Health Care Centers
- 1 November 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (11) , 3506-3514
- https://doi.org/10.1128/aac.47.11.3506-3514.2003
Abstract
In 1999, 39 of 2,599 isolates of the family Enterobacteriaceae (1.5%) collected by eight private laboratories in the Aquitaine region in France produced an extended-spectrum β-lactamase (ESBL). Among these were 19 Enterobacter aerogenes isolates; 8 Klebsiella pneumoniae isolates; 6 Escherichia coli isolates; 3 Proteus mirabilis isolates; and 1 isolate each of Serratia marcescens , Morganella morganii , and Providencia stuartii . ESBL producers were isolated from 38 patients, including 33 residents of 11 clinics or nursing homes and 5 ambulatory patients. Seven different ESBLs were characterized. These mainly consisted of TEM-24 (25 isolates) and TEM-21 (9 isolates), but TEM-15 (2 isolates) and TEM-3, TEM-19, SHV-4, and CTX-M-1 (1 isolate each) were also characterized. Seven strains showed the coexistence of different TEM- and/or SHV-encoding genes, including a new SHV-1 variant, SHV-44, defined by the substitution R205L previously reported for SHV-3 in association with S238G. The epidemiology of the ESBL producers was investigated by random amplification of polymorphic DNA, typing by enterobacterial repetitive intergenic consensus PCR, analysis of resistance cotransferred with the ESBL, and analysis of the restriction profiles of the ESBL-encoding plasmids. Of the TEM-24-expressing strains, 18 were E. aerogenes isolates, including 9 from the same clinic, that were representatives of the epidemic clone disseminating in France. Of the TEM-21-producing strains that belonged to different species of the family Enterobacteriaceae ( E. coli , K. pneumoniae , and P. mirabilis ), 8 were isolated in the same nursing home. Outbreaks due to strain and/or plasmid dissemination in these clinic and nursing home were demonstrated. The presence of ESBL producers in five ambulatory patients probably resulted from nosocomial acquisition. Our data highlight the serious need to monitor patients for ESBL-producing Enterobacteriaceae in general practice.Keywords
This publication has 52 references indexed in Scilit:
- Comité de l'Antibiogramme de la Société Française de Microbiologie Report 2003,International Journal of Antimicrobial Agents, 2003
- Clinical Strain of Pseudomonas aeruginosa Carrying a bla TEM-21 Gene Located on a Chromosomal Interrupted Tn A Type TransposonAntimicrobial Agents and Chemotherapy, 2002
- Susceptibility of Enterobacteriaceae to β-lactam agents and fluoroquinolones: a 3-year survey in FranceClinical Microbiology & Infection, 2002
- Molecular Characterization of a Novel Class 1 Integron Containing bla GES-1 and a Fused Product of aac(3)-Ib/aac(6 " )-Ib " Gene Cassettes in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2002
- SHV-16, a β-Lactamase with a Pentapeptide Duplication in the Omega LoopAntimicrobial Agents and Chemotherapy, 2001
- Evidence of In Vivo Transfer of a Plasmid Encoding the Extended-Spectrum β-Lactamase TEM-24 and Other Resistance Factors among Different Members of the Family EnterobacteriaceaeJournal of Clinical Microbiology, 2001
- Has resistance spread to the community?Clinical Microbiology & Infection, 2000
- Antibiotic Susceptibility of Bacterial Strains Isolated from Patients with Community-Acquired Urinary Tract Infections in FranceEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Control of a Prolonged Outbreak of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in a University HospitalClinical Infectious Diseases, 1999
- Investigation of outbreaks of Enterobacter aerogenes colonisation and infection in intensive care units by random amplification of polymorphic DNAJournal of Medical Microbiology, 1996